Anthropic Says Its AI Model Claude Discovered a CRISPR-Like Enzyme System
Anthropic has announced that its Claude AI model identified a new enzyme system resembling CRISPR gene-editing technology, amid ongoing global debate over how to guard against catastrophic risks posed by advanced artificial intelligence.
US artificial intelligence company Anthropic has said its Claude model made a scientific discovery, identifying an enzyme system comparable in function to CRISPR, the widely used gene-editing technology. The company is presenting the finding as evidence that advanced AI systems are now capable of generating original scientific insights rather than simply processing or summarizing existing knowledge.
The announcement comes at a time when governments, researchers and technology companies are engaged in intense discussions about how to responsibly manage increasingly powerful AI systems and prevent them from causing catastrophic harm. Anthropic has positioned itself publicly as an advocate for balancing rapid AI development with strong safety measures, and the unveiling of this discovery fits into that broader narrative about artificial intelligence's dual nature — as a tool with the potential to benefit science and medicine, and as a technology that requires careful oversight.
The company has not disclosed full technical details about how Claude arrived at the discovery, but the announcement itself signals a growing emphasis among AI developers on showcasing their models' potential contributions to biology and genetics. CRISPR-based tools have become one of the most influential methods in gene editing over the past decade, and the identification of a similar enzyme system could expand the possibilities available to researchers in this field.
Anthropic has framed the discovery within its broader message that AI technology should be developed responsibly, while also acknowledging its potential to deliver tangible benefits for scientific research.
